These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 15317873

  • 1. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
    Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D.
    Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
    [Abstract] [Full Text] [Related]

  • 2. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.
    Stamatakis K, Sánchez-Gómez FJ, Pérez-Sala D.
    J Am Soc Nephrol; 2006 Jan; 17(1):89-98. PubMed ID: 16291835
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K, Cheng S, Martel-Pelletier J, Afif H, Pelletier JP, Li X, Ranger P, Fahmi H.
    Arthritis Rheum; 2005 Jan 01; 52(1):94-104. PubMed ID: 15641079
    [Abstract] [Full Text] [Related]

  • 5. 15-Deoxy-Delta(12,14)-prostaglandin J(2) suppresses IL-6-induced STAT3 phosphorylation via electrophilic reactivity in endothelial cells.
    Wung BS, Wu CC, Hsu MC, Hsieh CW.
    Life Sci; 2006 May 22; 78(26):3035-42. PubMed ID: 16413037
    [Abstract] [Full Text] [Related]

  • 6. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
    Pena-dos-Santos DR, Severino FP, Pereira SA, Rodrigues DB, Cunha FQ, Vieira SM, Napimoga MH, Clemente-Napimoga JT.
    Neuroscience; 2009 Nov 10; 163(4):1211-9. PubMed ID: 19647045
    [Abstract] [Full Text] [Related]

  • 7. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.
    Napimoga MH, Souza GR, Cunha TM, Ferrari LF, Clemente-Napimoga JT, Parada CA, Verri WA, Cunha FQ, Ferreira SH.
    J Pharmacol Exp Ther; 2008 Jan 10; 324(1):313-21. PubMed ID: 17928570
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
    Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M.
    Mol Pharmacol; 2007 Nov 10; 72(5):1246-57. PubMed ID: 17673570
    [Abstract] [Full Text] [Related]

  • 9. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD.
    Mol Pharmacol; 2005 Jul 10; 68(1):169-78. PubMed ID: 15821150
    [Abstract] [Full Text] [Related]

  • 10. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
    Kim EH, Surh YJ.
    Biochem Pharmacol; 2006 Nov 30; 72(11):1516-28. PubMed ID: 16987499
    [Abstract] [Full Text] [Related]

  • 11. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism.
    Olmos G, Conde I, Arenas I, Del Peso L, Castellanos C, Landazuri MO, Lucio-Cazana J.
    Cell Signal; 2007 Oct 30; 19(10):2098-105. PubMed ID: 17658243
    [Abstract] [Full Text] [Related]

  • 12. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome.
    Shibata T, Yamada T, Kondo M, Tanahashi N, Tanaka K, Nakamura H, Masutani H, Yodoi J, Uchida K.
    Biochemistry; 2003 Dec 02; 42(47):13960-8. PubMed ID: 14636064
    [Abstract] [Full Text] [Related]

  • 13. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW.
    Life Sci; 2009 Jul 03; 85(1-2):46-53. PubMed ID: 19409914
    [Abstract] [Full Text] [Related]

  • 14. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
    Liu JD, Lin SY, Ho YS, Pan S, Hung LF, Tsai SH, Lin JK, Liang YC.
    Mol Carcinog; 2003 May 03; 37(1):16-24. PubMed ID: 12720296
    [Abstract] [Full Text] [Related]

  • 15. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
    Emi M, Maeyama K.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1259-67. PubMed ID: 15013841
    [Abstract] [Full Text] [Related]

  • 16. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun 01; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 17. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells.
    Sabichi AL, Subbarayan V, Llansa N, Lippman SM, Menter DG.
    Cancer Epidemiol Biomarkers Prev; 2004 Nov 01; 13(11 Pt 1):1704-9. PubMed ID: 15533896
    [Abstract] [Full Text] [Related]

  • 18. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
    Ueki S, Kato H, Kobayashi Y, Ito W, Adachi T, Nagase H, Ohta K, Kayaba H, Chihara J.
    Int Arch Allergy Immunol; 2007 Nov 01; 143 Suppl 1():15-22. PubMed ID: 17541271
    [Abstract] [Full Text] [Related]

  • 19. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.
    Yokoyama Y, Masaki T, Kiribayashi K, Nakashima A, Kokoroishi K, Ogawa T, Kohno N, Yorioka N.
    Ther Apher Dial; 2010 Feb 01; 14(1):43-51. PubMed ID: 20438519
    [Abstract] [Full Text] [Related]

  • 20. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state.
    Katura T, Moriya T, Nakahata N.
    Mol Pharmacol; 2010 Apr 01; 77(4):601-11. PubMed ID: 20086036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.